{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:16:24Z","timestamp":1787008584927,"version":"build-2736575974"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,16]]},"abstract":"<jats:p>We described three patients with Netherton syndrome in Malaysia treated with secukinumab with variable outcomes. To date, there have only been reports of about eight patients being treated with secukinumab globally with this condition, with good outcomes. We hope our observation will add to the existing global pool of information about Netherton syndrome treated with secukinumab.<\/jats:p>","DOI":"10.1093\/ced\/llad253","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T06:28:51Z","timestamp":1690525731000},"page":"1366-1369","source":"Crossref","is-referenced-by-count":4,"title":["Secukinumab for Netherton syndrome: a\u00a0Malaysian experience"],"prefix":"10.1093","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6476-8073","authenticated-orcid":false,"given":"Ingrid Pao Lin","family":"Ting","sequence":"first","affiliation":[{"name":"Department of Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyan Shin","family":"Lee","sequence":"additional","affiliation":[{"name":"Pediatric Dermatology Unit, Hospital Kuala Lumpur , Kuala Lumpur, Wilayah Persekutuan, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hock Gin","family":"Teo","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta","family":"Albela","sequence":"additional","affiliation":[{"name":"Pediatrics, Sarawak General Hospital , Kuching, Sarawak , Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Moon","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Dermatology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kin Fon","family":"Leong","sequence":"additional","affiliation":[{"name":"Pediatric Dermatology Unit, Hospital Kuala Lumpur , Kuala Lumpur, Wilayah Persekutuan, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"2023111605084592800_llad253-B1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jaci.2009.06.009","article-title":"Comel-Netherton syndrome defined as primary immunodeficiency","volume":"124","author":"Renner","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"2023111605084592800_llad253-B2","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jdcr.2020.04.025","article-title":"Successful use of secukinumab in Netherton syndrome","volume":"6","author":"Blanchard","year":"2020","journal-title":"JAAD Case Rep"},{"key":"2023111605084592800_llad253-B3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.annder.2022.08.005","article-title":"Secukinumab: a life-changing treatment for Netherton syndrome?","volume":"150","author":"Kaikati","year":"2023","journal-title":"Ann Dermatol Venereol"},{"key":"2023111605084592800_llad253-B4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/ajd.13880","article-title":"Secukinumab use in the treatment of Netherton's syndrome","volume":"63","author":"Gan","year":"2022","journal-title":"Australas J Dermatol"},{"key":"2023111605084592800_llad253-B5","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jamadermatol.2020.1019","article-title":"Secukinumab therapy for Netherton syndrome","volume":"156","author":"Luchsinger","year":"2020","journal-title":"JAMA Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llad253\/51443808\/llad253.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/12\/1366\/53456419\/llad253.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/48\/12\/1366\/53456419\/llad253.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:09:38Z","timestamp":1700093378000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/48\/12\/1366\/7232813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":5,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,7,28]]},"published-print":{"date-parts":[[2023,11,16]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llad253","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,7,28]]}}}